Neurocognitive Functioning in Type 1 and Type 2 Diabetes Mellitus

  • Eelco van DuinkerkenEmail author
  • Augustina M. A. Brands


Neuropsychology traditionally studies the effect of neurological diseases, such as stroke and dementia, on cognitive functioning. The focus on non-neurological diseases, including diabetes, has grown over the last decades. In this chapter we summarize the current literature with respect to cognitive functioning in patients with type 1 and type 2 diabetes. Both types of diabetes seem to affect similar cognitive domains with similar effect sizes. Risk factors largely pertain to the effects of chronic hyperglycemic exposure, macrovascular comorbidity, and psychiatric conditions. With the rapidly increasing prevalence of diabetes and life expectancy, the development of dementia is important to take into account. We therefore discuss the current understanding of the relationship between diabetes and dementia and how antidiabetic medication may have a protective effect. In the last sections, we will detail the clinical relevance of cognitive decrements found in studies and what we think are the most important future questions to be answered.


Type 1 diabetes Type 2 diabetes Neurocognitive function Neuropsychological function Dementia 


  1. Abramovitch, A., Mittelman, A., Tankersley, A. P., Abramowitz, J. S., & Schweiger, A. (2015). Neuropsychological investigations in obsessive-compulsive disorder: A systematic review of methodological challenges. Psychiatry Research, 228(1), 112–120.PubMedCrossRefGoogle Scholar
  2. Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., … Kivipelto, M. (2010). Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study. Neurology, 75(13), 1195–1202.PubMedCrossRefGoogle Scholar
  3. Awad, N., Gagnon, M., & Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26(8), 1044–1080.PubMedCrossRefGoogle Scholar
  4. Biessels, G. J., Deary, I. J., & Ryan, C. M. (2008). Cognition and diabetes: A lifespan perspective. Lancet Neurology, 7(2), 184–190.PubMedCrossRefGoogle Scholar
  5. Brands, A. M., Biessels, G. J., de Haan, E. H., Kappelle, L. J., & Kessels, R. P. (2005). The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care, 28(3), 726–735.PubMedCrossRefGoogle Scholar
  6. Brands, A. M., Kessels, R. P., Hoogma, R. P., Henselmans, J. M., van der Beek Boter, J. W., Kappelle, L. J., … Biessels, G. J. (2006). Cognitive performance, psychological Well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes, 55(6), 1800–1806.PubMedCrossRefGoogle Scholar
  7. Brands, A. M., van den Berg, E., Manschot, S. M., Biessels, G. J., Kappelle, J. L., de Haan, E. H., & Kessels, R. P. (2007a). A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. Journal of the International Neuropsychological Society, 13, 288–297.Google Scholar
  8. Brands, A. M. A., Biessels, G. J., Kappelle, L. J., de Haan, E. H. F., de Valk, H. W., Algra, A., & Kessels, R. P. C. (2007b). Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: A comparative study. Dementia and Geriatric Cognitive Disorders, 23, 343–350.PubMedCrossRefGoogle Scholar
  9. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813–820.PubMedCrossRefGoogle Scholar
  10. Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54, 1615–1625.PubMedCrossRefGoogle Scholar
  11. Bruehl, H., Wolf, O. T., Sweat, V., Tirsi, A., Richardson, S., & Convit, A. (2009). Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Research, 1280, 186–194.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Cheng, G., Huang, C., Deng, H., & Wang, H. (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Internal Medicine Journal, 42(5), 484–491.PubMedCrossRefGoogle Scholar
  13. Chung, C. C., Pimentel, D., Jordan, A. J., Hao, Y., Milberg, W., & Novak, V. (2015). Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology, 85, 1–9.CrossRefGoogle Scholar
  14. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.Google Scholar
  15. Cox, D. J., Kovatchev, B. P., Anderson, S. M., Clarke, W. L., & Gonder-Frederick, L. A. (2010). Type 1 diabetic drivers with and without a history of recurrent hypoglycemia–related driving mishaps. Diabetes Care, 33(11), 2430–2435.PubMedPubMedCentralCrossRefGoogle Scholar
  16. De Jong, R. (1950). The nervous system complications in diabetes mellitus with special reference to cerebrovascular changes. The Journal of Nervous and Mental Disease, 111, 181–206.CrossRefGoogle Scholar
  17. Domínguez, R. O., Marschoff, E. R., González, S. E., Repetto, M. G., & Serra, J. A. (2012). Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer’s disease patients. Diabetes Research and Clinical Practice, 98(1), 68–74.PubMedCrossRefGoogle Scholar
  18. Exalto, L. G., Biessels, G. J., Karter, A. J., Huang, E. S., Katon, W. J., Minkoff, J. R., & Whitmer, R. A. (2013). Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study. The Lancet Diabetes and Endocrinology. Epub ahead of print.
  19. Foundation WID. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of the WHO/IDF consultation. Geneva, Switzerland: World Health Organization.Google Scholar
  20. Guerrero-Berroa, E., Schmeidler, J., & Beeri, M. S. (2014). Neuropathology of type 2 diabetes: A short review on insulin-related mechanisms. European Neuropsychopharmacology, 24(12), 1961–1966.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Harada, C. N., Natelson Love, M. C., & Triebel, K. L. (2013). Normal cognitive aging. Clinics in Geriatric Medicine, 29, 737–752.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Hsu, C. C., Wahlqvist, M. L., Lee, M. S., & Tsai, H. N. (2011). Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. Journal of Alzheimer’s Disease, 24(3), 485–493.PubMedCrossRefPubMedCentralGoogle Scholar
  23. Hugenschmidt, C. E., Lovato, J. F., Ambrosius, W. T., Bryan, R. N., Gerstein, H. C., Horowitz, K. R., … Ding, J. (2014). The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care, 37, 3244–3252.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012). Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: A population-based case–control study. Journal of the American Geriatrics Society, 60(5), 916–921.PubMedCrossRefPubMedCentralGoogle Scholar
  25. Katon, W., Pedersen, H., Ribe, A., Fenger-Grøn, M., Davydow, D., Boch Waldorff, F., & Vestergaard, M. (2015). Effect of depression and diabetes mellitus on the risk for dementia: A national population-based cohort study. JAMA Psychiatry, 72(6), 612–619.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Kester, M. I., van der Flier, W. M., Mandic, G., Blankenstein, M. A., Scheltens, P., & Muller, M. (2010). Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer’s disease. Journal of Alzheimer's Disease, 20(4), 1083–1090.PubMedCrossRefPubMedCentralGoogle Scholar
  27. Lezak, M. D. (2012). Neuropsychological assessment. Oxford: Oxford University Press.Google Scholar
  28. Lin, E. H., Rutter, C. M., Katon, W., Heckbert, S. R., Ciechanowski, P., Oliver, M. M., … Von Korff, M. (2010). Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care, 33, 264–269.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Luchsinger, J. A., Palmas, W., Teresi, J. A., Silver, S., Kong, J., Eimicke, J. P., … Shea, S. (2011). Improved diabetes control in the elderly delays global cognitive decline. The Journal of Nutrition, Health & Aging, 15(6), 445–449.CrossRefGoogle Scholar
  30. Miles, W. R., & Root, H. F. (1922). Psychologic tests applied to diabetic patients. Archives of Internal Medicine, 30(6), 767–777.CrossRefGoogle Scholar
  31. Musen, G., Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., … T. D. E. R. Group. (2008). The impact of diabetes and its treatment on cognitive function among adolescents who participated in the DCCT. Diabetes Care, 31, 1933–1938.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Nelson, P. T., Smith, C. D., Abner, E. A., Schmitt, F. A., Scheff, S. W., Davis, G. J., … Markesbery, W. R. (2009). Human cerebral neuropathology of type 2 diabetes mellitus. Biochimica et Biophysica Acta, 1792, 454–469.PubMedCrossRefGoogle Scholar
  33. Northam, E. A., Anderson, P. J., Werther, G. A., Warne, G. L., Adler, R. G., & Andrewes, D. (1998). Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care, 21, 379–384.PubMedCrossRefGoogle Scholar
  34. Ouwens, D. M., van Duinkerken, E., Schoonenboom, S. N. M., Herzfeld de Wiza, D., Klein, M., van Golen, L., … Diamant, M. (2014). Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes. Diabetologia, 57, 2208–2214.PubMedCrossRefGoogle Scholar
  35. Palta, P., Schneider, A. L. C., Biessels, G. J., Touradji, P., & Hill-Briggs, F. (2014). Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. Journal of International Neurpsychological Society, 20, 278–291.CrossRefGoogle Scholar
  36. Patiño-Fernández, A. M., Delamater, A. M., Applegate, E. B., Brady, E., Eidson, M., Nemery, R., … Richton, S. (2010). Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes, 11, 424–430.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Patrone, C., Eriksson, O., & Lindholm, D. (2014). Diabetes drugs and neurological disorders: New views and therapeutic possibilities. The Lancet Diabetes and Endocrinology, 2(3), 256–262.PubMedCrossRefGoogle Scholar
  38. Reske-Nielsen, E., & Lundbæk, K. (1968). Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia, 4(1), 34–43.PubMedCrossRefGoogle Scholar
  39. Reske-Nielsen, E., Lundbæk, K., & Rafaelsen, O. J. (1966). Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia, 1(3), 233–241.PubMedCrossRefGoogle Scholar
  40. Roberts, R. O., Knopman, D. S., Przybelski, S. A., Mielke, M. M., Kantarci, K., Preboske, G. M., … Jack, C. R. J. (2014). Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology, 82, 1132–1141.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Roriz-Filho, J. S., Sá-Roriz, T. M., Rosset, I., Camozzato, A. L., Santos, A. C., Chaves, M. L. F., … Roriz-Cruz, M. (2009). (Pre)diabetes, brain aging, and cognition. Biochimica et Biophysica Acta, 1792(5), 432–443.CrossRefGoogle Scholar
  42. Roy, S., Kim, N., Desai, A., Komaragiri, M., Baxi, N., Jassil, N., … Hunter, K. (2015). Cognitive function and control of type 2 diabetes mellitus in young adults. North American Journal of Medical Sciences, 7, 220–226.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Ryan, C. (2006). Diabetes and brain damage: More (or less) than meets the eye? Diabetologia, 49(10), 2229–2233.PubMedCrossRefGoogle Scholar
  44. Ryan, C. M., Geckle, M. O., & Orchard, T. J. (2003). Cognitive efficiency declines over time in adults with type 1 diabetes: Effects of micro- and macrovascular complications. Diabetologia, 46(7), 940–948.PubMedCrossRefGoogle Scholar
  45. Smolina, K., Wotton, C. J., & Goldacre, M. J. (2015). Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998–2011: A retrospective national record linkage cohort study. Diabetologia, 58, 942–950.PubMedCrossRefGoogle Scholar
  46. Snoek, F. J., Bremmer, M. A., & Hermanns, N. (2015). Constructs of depression and distress in diabetes: Time for an appraisal. The Lancet Diabetes and Endocrinology, 3, 450–460.PubMedCrossRefGoogle Scholar
  47. Sonnen, J. A., Larson, E. B., Brickell, K., et al. (2009). Different patterns of cerebral injury in dementia with or without diabetes. Archives of Neurology, 66(3), 315–322.PubMedPubMedCentralCrossRefGoogle Scholar
  48. Spauwen, P. J. J., Köhler, S., Verhey, F. R. J., Stehouwer, C. D. A., & van Boxtel, M. P. J. (2013). Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study. Diabetes Care, 36, 1554–1561.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Sullivan, M. D., Katon, W. J., Lovato, L. C., Miller, M. E., Murray, A. M., Horowitz, K. R., … Launer, L. J. (2013). Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the accord-mind trial. JAMA Psychiatry, 70, 1041–1047.PubMedPubMedCentralCrossRefGoogle Scholar
  50. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. (2007). Long-term effect of diabetes and its treatment on cognitive function. The New England Journal of Medicine, 356(18), 1842–1852.CrossRefGoogle Scholar
  51. Tonoli, C., Heyman, E., Roelands, B., Pattyn, N., Buyse, L., Piacentini, M. F., … Meeusen, R. (2014). Type 1 diabetes-associated cognitive decline: A meta-analysis and update of the current literature 1型糖尿病相关的认知能力下降:一项对最新文献的meta分析. Journal of Diabetes, 6, 499–513.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Tuligenga, R. H., Dugravot, A., Tabák, A. G., Elbaz, A., Brunner, E. J., Kivimäki, M., & Singh-Manoux, A. (2014). Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: A post-hoc analysis of the Whitehall II cohort study. The Lancet Diabetes and Endocrinology, 2(3), 228–235.PubMedCrossRefPubMedCentralGoogle Scholar
  53. van den Berg, E., Biessels, G. J., de Craen, A. J. M., Gussekloo, J., & Westendorp, R. G. J. (2007). The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology, 69(10), 979–985.PubMedCrossRefPubMedCentralGoogle Scholar
  54. van den Berg, E., de Craen, A., Biessels, G., Gussekloo, J., & Westendorp, R. (2006). The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia, 49(9), 2015–2023.PubMedCrossRefGoogle Scholar
  55. van den Berg, E., Dekker, J. M., Nijpels, G., Kessels, R. P., Kappelle, L. J., de Haan, E. H., … Biessels, G. J. (2008). Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dementia and Geriatric Cognitive Disorders, 26(3), 261–269.PubMedCrossRefGoogle Scholar
  56. van den Berg, E., Kloppenborg, R. P., Kessels, R. P. C., Kappelle, L. J., & Biessels, G. J. (2009). Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochimica et Biophysica Acta, 1792, 470–481.PubMedCrossRefGoogle Scholar
  57. van den Berg, E., Reijmer, Y., de Bresser, J., Kessels, R., Kappelle, L., Biessels, G., & and on behalf of the Utrecht Diabetic Encephalopathy Study. (2010). A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia, 53(1), 58–65.PubMedCrossRefGoogle Scholar
  58. van Dooren, F. E., Nefs, G., Schram, M. T., Verhey, F. R. J., Denollet, J., & Pouwer, F. (2013). Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLoS One, 8, e57058. Scholar
  59. van Duinkerken, E., Brands, A. M. A., van den Berg, E., Henselmans, J. M. L., Hoogma, R. P. L. M., Biessels, G. J., & On behalf of the Utrecht Diabetic Encephalopathy Study Group. (2011). Cognition in older patients with type 1 diabetes mellitus: A longitudinal study. Journal of the American Geriatrics Society, 59, 563–565.PubMedCrossRefGoogle Scholar
  60. van Duinkerken, E., Schoonheim, M. M., Sanz-Arigita, E. J., IJzerman, R. G., Moll, A. C., Snoek, F. J., … Barkhof, F. (2012). Resting-state brain networks in type 1 diabetes patients with and without microangiopathy and their relation with cognitive functions and disease variables. Diabetes, 61, 1814–1821.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., … Craft, S. (2003). Insulin increases CSF Ab42 levels in normal older adults. Neurology, 60(12), 1899–1903.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Eelco van Duinkerken
    • 1
    • 2
    Email author
  • Augustina M. A. Brands
    • 3
  1. 1.Department of Medical PsychologyAmsterdam University Medical CentersAmsterdamThe Netherlands
  2. 2.Center for EpilepsyInstituto Estadual do Cérebro Paulo NiemeyerRio de JaneiroBrazil
  3. 3.Franciscus Gasthuis & Vlietland HospitalRotterdamThe Netherlands

Personalised recommendations